913814-41-2

Upstream product

• 913814-40-1 (3R,5S,7R)-3-benzyloxy-1-(4-benzyloxyphenyl)eicosane-5,7-diol 
• 77-76-9 2,2-dimethoxy-propane 
• 871809-93-7 (+)-(3R)-1-[4-(benzyloxy)phenyl]hex-5-en-3-ol 
• 100-39-0 benzyl bromide 
• 913814-38-7 (3R,7R)-3-Benzyloxy-1-(4-benzyloxy-phenyl)-7-hydroxy-icosan-5-one 
• 871809-95-9 (R)-4-benzyloxy-6-(4-benzyloxyphenyl)hexan-2-one 
• 871809-94-8 (R)-4-benzyloxy-6-(4-benzyloxyphenyl)hex-1-ene 

Downstream Products

• 913814-43-4 4-[(3R,5R,7R)-5,7-bis(tert-butyldimethylsilyloxy)-3-hydroxyeicosyl]phenol 
• 913814-44-5 (5S,7R)-5,7-di[1-(tert-butyl)-1,1-dimethylsilyl]oxy-1-(4-hydroxyphenyl)icosan-3-one 
• 913814-42-3 1-benzyloxy-4-[(3R,5R,7R)-3-benzyloxy-5,7-bis(tert-butyldimethylsilyloxy)eicosyl]benzene 

Relevant academic research and scientific papers

Enantioselective synthesis and absolute configurations of aculeatins A, B, D, and 6-epi-aculeatin D

The three naturally occurring, bioactive spiroacetals aculeatins A, B, and D, as well as the non-natural 6-epi-aculeatin D have been synthesized for the first time in enantiopure form using an asymmetric allylation as the only chirality source. A further